Bluejay Diagnostics, Inc. Finance Lease, Principal Payments
Bluejay Diagnostics, Inc. (BJDX) reported Finance Lease, Principal Payments of $282 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-12
- Bluejay Diagnostics, Inc. finance lease, principal payments for the quarter ending 2026-06-30 was $132.00, a 36.23% decline year-over-year.
- Bluejay Diagnostics, Inc. finance lease, principal payments for the quarter ending 2026-03-31 was $150.00, a 30.88% decline year-over-year.
- Bluejay Diagnostics, Inc. finance lease, principal payments for the quarter ending 2025-12-31 was $168.00, a 29.71% decline year-over-year.
- Bluejay Diagnostics, Inc. finance lease, principal payments for the quarter ending 2025-09-30 was $188.00, a 26.27% decline year-over-year.
- Bluejay Diagnostics, Inc. finance lease, principal payments for fiscal 2025 was $780.00, a 25.93% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. finance lease, principal payments for fiscal 2024 was $1.05K, a 19.31% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. finance lease, principal payments for fiscal 2023 was $1.30K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 3 month as first filed | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 6 month as first filed | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 9 month as first filed | Finance Lease, Principal Payments 12 month | Finance Lease, Principal Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $132.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $282.00 10-Q · filed 2026-08-12 | $450.00 derived: sum of 3 quarters · filed 2026-08-12 | $638.00 derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $150.00 10-Q · filed 2026-05-07 | $318.00 derived: sum of 2 quarters · filed 2026-05-07 | $506.00 derived: sum of 3 quarters · filed 2026-05-07 | $713.00 derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $168.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $356.00 derived: sum of 2 quarters · filed 2026-03-06 | $563.00 derived: sum of 3 quarters · filed 2026-08-12 | $780.00 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | $188.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $395.00 derived: sum of 2 quarters · filed 2026-08-12 | $612.00 10-Q · filed 2025-11-07 | $851.00 derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $207.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $424.00 10-Q · filed 2026-08-12 | $663.00 derived: sum of 3 quarters · filed 2026-08-12 | $918.00 derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $217.00 10-Q · filed 2026-05-07 | $456.00 derived: sum of 2 quarters · filed 2026-05-07 | $711.00 derived: sum of 3 quarters · filed 2026-05-07 | $982.00 derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $239.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $494.00 derived: sum of 2 quarters · filed 2026-03-06 | $765.00 derived: sum of 3 quarters · filed 2026-03-06 | $1.05K 10-K · filed 2026-03-06 | ||||
| 2024-09-30 | $255.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $526.00 derived: sum of 2 quarters · filed 2025-11-07 | $814.00 10-Q · filed 2025-11-07 | $3.60K 10-Q · filed 2024-11-07 | -$1.49K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $271.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $559.00 10-Q · filed 2025-08-07 | $2.40K 10-Q · filed 2024-08-14 | -$1.74K derived: sum of 3 quarters · filed 2025-08-07 | -$539.00 derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $288.00 10-Q · filed 2025-05-13 | $4.81K 10-Q · filed 2024-05-15 | -$2.01K derived: sum of 2 quarters · filed 2025-05-13 | -$810.00 derived: sum of 3 quarters · filed 2025-05-13 | $391.00 derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$2.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.10K derived: sum of 2 quarters · filed 2025-03-31 | $103.00 derived: sum of 3 quarters · filed 2025-03-31 | $1.30K 10-K · filed 2025-03-31 | $4.81K 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $1.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.40K derived: sum of 2 quarters · filed 2024-11-07 | $3.60K 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.40K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | $1.20K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |